BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34974973)

  • 1. The increasing importance of LNAA supplementation in phenylketonuria at higher plasma phenylalanine concentrations.
    van Vliet D; van der Goot E; van Ginkel WG; van Faassen HJR; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Mol Genet Metab; 2022 Jan; 135(1):27-34. PubMed ID: 34974973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic brain modulation with targeted large neutral amino acid supplements in the Pah-enu2 phenylketonuria mouse model.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Pascucci T; Puglisi-Allegra S; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Am J Clin Nutr; 2016 Nov; 104(5):1292-1300. PubMed ID: 27655443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Benefit of Large Neutral Amino Acid Supplementation to a Liberalized Phenylalanine-Restricted Diet in Adult Phenylketonuria Patients: Evidence from Adult
    van Vliet D; van der Goot E; van Ginkel WG; van Faassen MHJR; de Blaauw P; Kema IP; Martinez A; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31546852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large neutral amino acid supplementation as an alternative to the phenylalanine-restricted diet in adults with phenylketonuria: evidence from adult Pah-enu2 mice.
    van Vliet D; van der Goot E; Bruinenberg VM; van Faassen M; de Blaauw P; Kema IP; Heiner-Fokkema MR; van der Zee EA; van Spronsen FJ
    J Nutr Biochem; 2018 Mar; 53():20-27. PubMed ID: 29175141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice.
    van Vliet D; Bruinenberg VM; Mazzola PN; van Faassen MH; de Blaauw P; Kema IP; Heiner-Fokkema MR; van Anholt RD; van der Zee EA; van Spronsen FJ
    PLoS One; 2015; 10(12):e0143833. PubMed ID: 26624009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of blood and brain biochemistry in phenylketonuria: Results from the Pah-enu2 PKU mouse.
    Dijkstra AM; van Vliet N; van Vliet D; Romani C; Huijbregts SCJ; van der Goot E; Hovens IB; van der Zee EA; Kema IP; Heiner-Fokkema MR; van Spronsen FJ
    Mol Genet Metab; 2021 Nov; 134(3):250-256. PubMed ID: 34656426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large neutral amino acids in the treatment of PKU: from theory to practice.
    van Spronsen FJ; de Groot MJ; Hoeksma M; Reijngoud DJ; van Rijn M
    J Inherit Metab Dis; 2010 Dec; 33(6):671-6. PubMed ID: 20976625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.
    Vogel KR; Arning E; Wasek BL; Bottiglieri T; Gibson KM
    Mol Genet Metab; 2013; 110 Suppl(0):S71-8. PubMed ID: 23999161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
    Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
    Yano S; Moseley K; Fu X; Azen C
    PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement, cloning, and expression of an in silico designed protein enriched with large neutral amino acids in Pichia pastoris for possible application in phenylketonuria.
    Appaiah P; Vasu P
    J Food Biochem; 2020 Mar; 44(3):e13151. PubMed ID: 31960483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker.
    Yano S; Moseley K; Azen C
    J Pediatr; 2013 May; 162(5):999-1003. PubMed ID: 23164313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Microbiome Composition in Response to Phenylketonuria Depends on Dietary Phenylalanine in BTBR Pah
    van der Goot E; Vink SN; van Vliet D; van Spronsen FJ; Falcao Salles J; van der Zee EA
    Front Nutr; 2021; 8():735366. PubMed ID: 35059423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
    MacDonald A; Singh RH; Rocha JC; van Spronsen FJ
    Nutr Res Rev; 2019 Jun; 32(1):70-78. PubMed ID: 30284526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
    Winn SR; Scherer T; Thöny B; Harding CO
    Mol Genet Metab; 2016 Jan; 117(1):5-11. PubMed ID: 26653793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.
    van Spronsen FJ; Smit PG; Koch R
    J Inherit Metab Dis; 2001 Feb; 24(1):1-4. PubMed ID: 11286377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.